Document Detail


Regulatory mechanisms of nucleic acid-mediated innate immune responses in the tumor microenvironment.
MedLine Citation:
PMID:  23264918     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
We identified novel mechanisms whereby TIM-3 suppresses innate immunity as induced by nucleic acids. Interaction of TIM-3 with HMGB1 inhibits the recruitment of nucleic acids to the endosomal compartment of dendritic cells, impairing the transduction of innate immune signals. Thus, TIM-3 is an effective target for enhancing the immunogenicity of nucleic acids in the context of cancer therapy.
Authors:
Masahisa Jinushi
Related Documents :
15593248 - Nmr spectroscopic data of some 1-alkoxy-2,2-di(carbonyl, carboxyl, cyano)-substituted e...
24600998 - How do organic vapors contribute to new-particle formation?
24767308 - Structure-dependent effects of pyridine derivatives on mechanisms of intestinal fatty a...
15640578 - 3-germyl-3,3-dimethylpropionic acid derivatives.
23357798 - Impact of α-amylase combined with hydrochloric acid hydrolysis on structure and digest...
1516848 - The role of extracellular medium components and specific amino acids in the cytotoxic r...
Publication Detail:
Type:  JOURNAL ARTICLE    
Journal Detail:
Title:  Oncoimmunology     Volume:  1     ISSN:  2162-4011     ISO Abbreviation:  Oncoimmunology     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-24     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101570526     Medline TA:  Oncoimmunology     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1632-1634     Citation Subset:  -    
Affiliation:
Research Center for Infection-Associated Cancer; Institute for Genetic Medicine; Hokkaido University; Sapporo, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Enhancing the antitumor effects of radiotherapy with combinations of immunostimulatory antibodies.
Next Document:  In vivo evidence for dendritic cell lysis by NK cells: Hints on improving cancer vaccines by targeti...